Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON). (Q42272174)
Jump to navigation
Jump to search
scientific article published on 28 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON). |
scientific article published on 28 February 2013 |
Statements
1 reference
Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON). (English)
1 reference
1 reference
Janet Wittes
1 reference
David G Warnock
1 reference
Hans-Henrik Parving
1 reference
Robert D Toto
1 reference
Tadao Akizawa
1 reference
Paul Audhya
1 reference
George L Bakris
1 reference
Melanie Chin
1 reference
Melissa Krauth
1 reference
Hiddo J Lambers Heerspink
1 reference
Colin J Meyer
1 reference
Nosratola D Vaziri
1 reference
Glenn M Chertow
1 reference
Dick de Zeeuw
1 reference
Rajiv Agarwal
1 reference
Pablo E Pergola
1 reference
Christoph Wanner
1 reference
28 February 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference